AstraZeneca’s Imfinzi gets speedy FDA review for small cell lung cancer
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange, U.S., April 8, 2019. REUTERS/Brendan McDermid (Reuters)…